Palantir's Q4 earnings exceeded expectations, showing strong customer growth and operational efficiency. Read why I'm ...
Panhandle Royalty Company (PHX) stock soared to a 52-week high, reaching $4.18, as investors rallied behind the company's strong performance over the past year. With a market capitalization of $152.36 ...
Cathie Wood’s ARK line of ETFs made some significant trades yesterday, selling Palantir Technologies (PLTR) and Robinhood ...
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target lowered by equities researchers at Needham & Company LLC from $38.00 to $10.00 in a report released on Monday,Benzinga reports.
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.
Check out the latest The Pnc Financial Services Group Inc. (PNC) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant ...
2d
Hosted on MSNCanaccord Genuity Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results